Alpha-Blockers Market 2027 | The Insight Partners

Alpha-Blockers Market to 2027 - Global Analysis and Forecasts By Types (Non-selective Antagonists, Selective Antagonists); Applications (Hypertension, Raynaud's Disease, Erectile Dysfunction)

Report Code: TIPRE00007427 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Alpha-blocker lowers the blood pressure by keeping the hormone noradrenaline from tightening the muscles from the wall of smaller arteries and veins. As a result of it, the vessels remain open and relaxed that improves blood flow and lowers blood pressure. Earlier, alpha-blocker was used as a tool for pharmacologic research to develop a greater understating of the automatic nervous system. Alpha blockers include doxazosin mesylate (Cardura), prazosin hydrochloride (Minipress), and terazosin hydrochloride (Hytrin). Alpha blocker is most effective, least costly and best tolerated of the drugs the relieve LUTS(lower urinary tract symtoms).

MARKET DYNAMICS

The alpha-blockers market is anticipated to grow in the market by identifying significant trends and factors that are driving and inhibiting market growth. Analyzing the opportunities in the market for stakeholders and by identifying the high growth segment in the forecast period is driving the market growth.

MARKET SCOPE

The "Alpha-Blockers Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in alpha-blockers market with detailed market segmentation by types, applications and geography. The alpha-blockers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in alpha-blockers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The alpha-blockers market is segmented on the basis of types and by applications. Based on type the market is segmented as non-selective antagonists and selective antagonists. On the basis of applications the market is categorized as hypertension, raynaud's disease and erectile dysfunction.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in alpha-blockers market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The alpha-blockers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting alpha-blockers market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the alpha-blockers market in these regions.

MARKET PLAYERS


The report covers key developments in the in alpha-blockers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in alpha-blockers market are anticipated to have lucrative growth opportunities in the future with the rising demand for in alpha-blockers market in the global market. Below mentioned is the list of few companies engaged in the Alpha-Blockers market.

The report also includes the profiles of key in alpha-blockers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Astra Zeneca Pharmaceuticals LP
  •  Bayer AG
  •  Bristol-Myers Squibb Co.
  •  Eli Lilly and Company
  •  Johnson & Johnson Services, Inc.
  •  Merck & Co., Ltd.
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi SA
  •  Teva Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alpha-blockers Market - By Types
1.3.2 Alpha-blockers Market - By Applications
1.3.3 Alpha-blockers Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ALPHA-BLOCKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ALPHA-BLOCKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ALPHA-BLOCKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. ALPHA-BLOCKERS - GLOBAL MARKET OVERVIEW
6.2. ALPHA-BLOCKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ALPHA-BLOCKERS MARKET - REVENUE AND FORECASTS TO 2027 - TYPES
7.1. OVERVIEW
7.2. TYPES MARKET FORECASTS AND ANALYSIS
7.3. NON-SELECTIVE ANTAGONISTS
7.3.1. Overview
7.3.2. Non-selective Antagonists Market Forecast and Analysis

7.4. SELECTIVE ANTAGONISTS
7.4.1. Overview
7.4.2. Selective Antagonists Market Forecast and Analysis

8. ALPHA-BLOCKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HYPERTENSION
8.3.1. Overview
8.3.2. Hypertension Market Forecast and Analysis
8.4. RAYNAUD'S DISEASE
8.4.1. Overview
8.4.2. Raynaud's Disease Market Forecast and Analysis
8.5. ERECTILE DYSFUNCTION
8.5.1. Overview
8.5.2. Erectile Dysfunction Market Forecast and Analysis
9. ALPHA-BLOCKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Alpha-blockers Market Overview
9.1.2 North America Alpha-blockers Market Forecasts and Analysis
9.1.3 North America Alpha-blockers Market Forecasts and Analysis - By Types
9.1.4 North America Alpha-blockers Market Forecasts and Analysis - By Applications
9.1.5 North America Alpha-blockers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Alpha-blockers Market
9.1.5.1.1 United States Alpha-blockers Market by Types
9.1.5.1.2 United States Alpha-blockers Market by Applications
9.1.5.2 Canada Alpha-blockers Market
9.1.5.2.1 Canada Alpha-blockers Market by Types
9.1.5.2.2 Canada Alpha-blockers Market by Applications
9.1.5.3 Mexico Alpha-blockers Market
9.1.5.3.1 Mexico Alpha-blockers Market by Types
9.1.5.3.2 Mexico Alpha-blockers Market by Applications
9.2. EUROPE
9.2.1 Europe Alpha-blockers Market Overview
9.2.2 Europe Alpha-blockers Market Forecasts and Analysis
9.2.3 Europe Alpha-blockers Market Forecasts and Analysis - By Types
9.2.4 Europe Alpha-blockers Market Forecasts and Analysis - By Applications
9.2.5 Europe Alpha-blockers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Alpha-blockers Market
9.2.5.1.1 Germany Alpha-blockers Market by Types
9.2.5.1.2 Germany Alpha-blockers Market by Applications
9.2.5.2 France Alpha-blockers Market
9.2.5.2.1 France Alpha-blockers Market by Types
9.2.5.2.2 France Alpha-blockers Market by Applications
9.2.5.3 Italy Alpha-blockers Market
9.2.5.3.1 Italy Alpha-blockers Market by Types
9.2.5.3.2 Italy Alpha-blockers Market by Applications
9.2.5.4 Spain Alpha-blockers Market
9.2.5.4.1 Spain Alpha-blockers Market by Types
9.2.5.4.2 Spain Alpha-blockers Market by Applications
9.2.5.5 United Kingdom Alpha-blockers Market
9.2.5.5.1 United Kingdom Alpha-blockers Market by Types
9.2.5.5.2 United Kingdom Alpha-blockers Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Alpha-blockers Market Overview
9.3.2 Asia-Pacific Alpha-blockers Market Forecasts and Analysis
9.3.3 Asia-Pacific Alpha-blockers Market Forecasts and Analysis - By Types
9.3.4 Asia-Pacific Alpha-blockers Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Alpha-blockers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Alpha-blockers Market
9.3.5.1.1 Australia Alpha-blockers Market by Types
9.3.5.1.2 Australia Alpha-blockers Market by Applications
9.3.5.2 China Alpha-blockers Market
9.3.5.2.1 China Alpha-blockers Market by Types
9.3.5.2.2 China Alpha-blockers Market by Applications
9.3.5.3 India Alpha-blockers Market
9.3.5.3.1 India Alpha-blockers Market by Types
9.3.5.3.2 India Alpha-blockers Market by Applications
9.3.5.4 Japan Alpha-blockers Market
9.3.5.4.1 Japan Alpha-blockers Market by Types
9.3.5.4.2 Japan Alpha-blockers Market by Applications
9.3.5.5 South Korea Alpha-blockers Market
9.3.5.5.1 South Korea Alpha-blockers Market by Types
9.3.5.5.2 South Korea Alpha-blockers Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Alpha-blockers Market Overview
9.4.2 Middle East and Africa Alpha-blockers Market Forecasts and Analysis
9.4.3 Middle East and Africa Alpha-blockers Market Forecasts and Analysis - By Types
9.4.4 Middle East and Africa Alpha-blockers Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Alpha-blockers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Alpha-blockers Market
9.4.5.1.1 South Africa Alpha-blockers Market by Types
9.4.5.1.2 South Africa Alpha-blockers Market by Applications
9.4.5.2 Saudi Arabia Alpha-blockers Market
9.4.5.2.1 Saudi Arabia Alpha-blockers Market by Types
9.4.5.2.2 Saudi Arabia Alpha-blockers Market by Applications
9.4.5.3 U.A.E Alpha-blockers Market
9.4.5.3.1 U.A.E Alpha-blockers Market by Types
9.4.5.3.2 U.A.E Alpha-blockers Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Alpha-blockers Market Overview
9.5.2 South and Central America Alpha-blockers Market Forecasts and Analysis
9.5.3 South and Central America Alpha-blockers Market Forecasts and Analysis - By Types
9.5.4 South and Central America Alpha-blockers Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Alpha-blockers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Alpha-blockers Market
9.5.5.1.1 Brazil Alpha-blockers Market by Types
9.5.5.1.2 Brazil Alpha-blockers Market by Applications
9.5.5.2 Argentina Alpha-blockers Market
9.5.5.2.1 Argentina Alpha-blockers Market by Types
9.5.5.2.2 Argentina Alpha-blockers Market by Applications

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ALPHA-BLOCKERS MARKET, KEY COMPANY PROFILES
11.1. ASTRA ZENECA PHARMACEUTICALS LP
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRISTOL-MYERS SQUIBB CO.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ELI LILLY AND COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JOHNSON AND JOHNSON SERVICES, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK AND CO., LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI SA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Astra Zeneca Pharmaceuticals LP
2. Bayer AG
3. Bristol-Myers Squibb Co.
4. Eli Lilly and Company
5. Johnson & Johnson Services, Inc.
6. Merck & Co., Ltd.
7. Novartis AG
8. Pfizer Inc.
9. Sanofi SA
10. Teva Pharmaceutical Industries Ltd